Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results

Go back to Infinity Pharmaceuticals Provides Company Update and First Quarter 2018 Financial Results

Infinity Pharma (INFI) Reports In-Line Q1 EPS

May 8, 2018 4:43 PM EDT

Infinity Pharma (NASDAQ: INFI) reported Q1 EPS of ($0.18), in-line with the analyst estimate of ($0.18).

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

... More